Product Information
EFFEXOR XR 75 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $19.8361 per EA under NDC 58151012677. Its NADAC has been published 86 times since Jan 1, 2025.
FDA first approved this application on Oct 20, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the VENLAFAXINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
75 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151012677
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020699FDA Approved
10/20/1997
TE Code
AB
On Market Since
10/30/2024
Pharmacological Classes
Price Statistics
The NADAC for EFFEXOR XR 75 MG CAPSULE has been published 86 times since Jan 1, 2025, and over the history we have for it it has risen 7.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.8361 per EA |
|---|---|
| All-time high | $19.8481 (May 13, 2026) |
| All-time low | $18.3997 (Jan 1, 2025) |
| 52-week high | $19.8481 |
| 52-week low | $18.9030 |
| Median price | $18.9516 |
| Average price | $19.2691 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 86 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EFFEXOR XR 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EFFEXOR XR 75 MG CAPSULE, manufactured by Viatris Specialty LLC, is $19.8361 per EA (NDC 58151012677), effective Aug 19, 2026.
How has the price of EFFEXOR XR 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EFFEXOR XR 75 MG CAPSULE has risen 7.8%. It has been tracked across 86 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for EFFEXOR XR 75 MG CAPSULE?
Since Jan 1, 2025, the NADAC for EFFEXOR XR 75 MG CAPSULE has ranged from a low of $18.3997 (Jan 1, 2025) to a high of $19.8481 (May 13, 2026), with a median of $18.9516 per EA.
Are there cheaper alternatives to EFFEXOR XR 75 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL ER 75 MG CAP, is $0.0794 per EA — about 99% below EFFEXOR XR 75 MG CAPSULE.
Who manufactures EFFEXOR XR 75 MG CAPSULE?
EFFEXOR XR 75 MG CAPSULE (NDC 58151012677) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.